Skip to main content
Clinical Trials/ACTRN12617001240336
ACTRN12617001240336
Withdrawn
N/A

High-intensity interval training in type 2 diabetes. Does it improve brain blood flow, cognitive function and reduce the risk of cerebrovascular disease?

niversity of Otago0 sites40 target enrollmentAugust 25, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
niversity of Otago
Enrollment
40
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 25, 2017
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • For those who identify as having type 2 diabetes.
  • Confirmed diagnosis of Type 2 diabetes
  • Aged between 40 \- 65 years
  • Able to give informed consent
  • For those who identify as healthy volunteers.
  • Aged between 40 \- 65 years
  • Able to give informed consent

Exclusion Criteria

  • For those who identify as having type 2 diabetes.
  • Unable to give informed consent
  • Any pre\-existing cardiovascular and cerebrovascular disease and peripheral neuropathy
  • Currently treated with beta\-blocker or rate control therapy
  • For those who identify as healthy volunteers.
  • Found to have undiagnosed type 2 diabetes.
  • Unable to give informed consent
  • Any pre\-existing cardiovascular and cerebrovascular disease and peripheral neuropathy
  • Currently treated with beta\-blocker or rate control therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials